NEAT1 and ischemic stroke: Furthermore, regulating the MIAT/EGLN2 axis and NEAT1/EGR1/RBM25 axis provides therapeutic strategies for ischemic stroke therapy (97, 99), and ETAR/miR-27b-3p/FBXW7/KLF5/GLI1 axis and miRNA-146-5p/USP3 axis may act as potential targets for PAH prevention and treatment (109, 114).